Focused Compounding Fund, LP issued an open letter to the shareholders of Parks! America, Inc
$PRKA
Focused Compounding’s Plan Prioritizes Return of Capital
Parks! America Criticizes Plan to Increase Liquidity for Shareholders
To the Owners of Parks! America:
Focused Compounding is a private investment fund and the largest shareholder of Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), owning approximately 38.44% of the issued and outstanding shares. We have been a significant shareholder of Parks! America for over four years, and like you have been frustrated by the Company’s continued poor performance.
We know many of you may want someone to buy your stock from you.
Earlier this year, the Company’s incumbent board adopted a “poison pill” making it impossible for any 10% or larger shareholder to purchase your shares. You won’t get any offers from 10% shareholders to buy your stock while that pill is in place.
We understand that this road block may be frustrating. Focused Compounding’s plan for Parks! America is built around a series of events designed to provide liquidity to shareholders, in addition to considering the termination of the poison pill. This can happen in one of two ways:
1) A tender offer or stock buy back: The Company offers to buy shares directly from you, whether through a tender or an announced share buy back. You get cash for your shares.
2) A special dividend. The Company declares a dividend and all shareholders receive cash.
The other side opposes returning your money to you.
They call it liquidating.
They want to keep your money from you.
We want to return your money to you.
Don’t get stuck in a stock that pays no dividends, with no Company buy backs, and shares that are nearly impossible to sell for another 14 years (assuming the future is the same as the past).
You’ve been through illiquidity hell with this Company for long enough. It’s time for a little liquidating (sell the bad stuff, keep the good stuff).
It’s time to get your money back to you.
Sincerely,
Focused Compounding
Source:
https://www.sec.gov/Archives/edgar/data/1297937/000199937124006482/prka-dfan14a_052224.htm